Bambusa Therapeutics (NASDAQ:BBTX) Stock: Insider Ra Capital Management, L.P. Purchases 2,500,000 Shares

Bambusa Therapeutics, Inc. (NASDAQ:BBTX – Get Free Report) Director Ra Capital Management, L.P. bought 2,500,000 shares of the company’s stock in a transaction dated Monday, November 2nd. The stock was bought at an average cost of $16.00 per share, for a total transaction of $40,000,000.00. Following the acquisition, the director owned 5,933,787 shares of the company’s stock, valued at approximately $94,940,592. This trade represents a 72.81% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Ra Capital Management, L.P. also recently made the following trade(s):

• On Friday, October 30th, Ra Capital Management, L.P. bought 453,820 shares of Bambusa Therapeutics stock. The stock was bought at an average cost of $14.63 per share, for a total transaction of $6,639,386.60.

Bambusa Therapeutics Price Performance

Shares of Bambusa Therapeutics stock remained flat at $16.00 during trading hours on Tuesday. The stock had a trading volume of 275,809 shares, compared to its average volume of 354,454. Bambusa Therapeutics, Inc. has a twelve month low of $13.60 and a twelve month high of $17.42.

Recommended Stories

• Five stocks we like better than Bambusa Therapeutics
• Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
• Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
• Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
• Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test